| From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence … J Stannah, JLF Anato, M Pickles, J Lamarange, KM Mitchell, A Artenie, ... BMC Medicine, 2024 | | 2024 |
| Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review A Stevens, JR Keemink, S Shirley‐Beavan, Z Khadjesari, A Artenie, ... Drug and alcohol review, 2024 | | 2024 |
| Modeling the impact of the COVID-19 pandemic on achieving HCV elimination amongst young and unstably housed people who inject drugs in San Francisco H Fraser, J Stone, SN Facente, A Artenie, S Patel, EC Wilson, ... International Journal of Drug Policy, 104452, 2024 | | 2024 |
| Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis A Levinsson, C Zolopa, F Vakili, S Udhesister, N Kronfli, M Maheu-Giroux, ... EClinicalMedicine 72, 2024 | 1 | 2024 |
| RE: Opioid agonist dosage adequacy from clinical and patient perspectives: Further considerations AA Artenie, J Bruneau | 1 | 2023 |
| PREPRINT: Overdose prevention centres as spaces of safety, trust and inclusion: a causal pathway based on a realist review A Stevens, JR Keemink, S Shirley-Beavan, Z Khadjesari, A Artenie, ... | | 2023 |
| Overdose prevention centres, safe consumption sites, and drug consumption rooms: A rapid evidence review GW Shorter, PE McKenna-Plumley, KBD Campbell, JR Keemink, ... Drug Science, 2023 | 8 | 2023 |
| Impact of HCV testing and treatment on HCV transmission among men who have sex with men and who inject drugs in San Francisco: a modelling analysis A Artenie, J Stone, SN Facente, H Fraser, J Hecht, P Rhodes III, ... The Journal of infectious diseases 228 (6), 662-673, 2023 | 5 | 2023 |
| Patient reported outcomes during and following HCV direct-acting antiviral treatment among people who inject drugs Q Cheng, EB Cunningham, S Shih, J Amin, J Bruneau, A Artenie, J Powis, ... Value in Health, 2023 | | 2023 |
| Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis A Artenie, J Stone, H Fraser, D Stewart, C Arum, AG Lim, AL McNaughton, ... The lancet Gastroenterology & hepatology 8 (6), 533-552, 2023 | 31 | 2023 |
| Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a … A Trickey, E Fajardo, D Alemu, AA Artenie, P Easterbrook The lancet Gastroenterology & hepatology 8 (3), 253-270, 2023 | 47 | 2023 |
| Impact of hepatitis C virus point-of-care (PoC) viral load assay compared to laboratory-based assays on uptake of testing and treatment, and turnaround times: a systematic … P Easterbrook, A Trickey, E Fajardo, D Alemu, A Artenie Journal of Hepatology 77, S556-S557, 2022 | | 2022 |
| A cross‐sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for … A Artenie, SN Facente, S Patel, J Stone, J Hecht, P Rhodes III, ... Health Science Reports 5 (4), 2022 | 10 | 2022 |
| Perceived availability and carriage of take-home naloxone and factors associated with carriage among people who inject drugs in England, Wales and Northern Ireland C Spring, S Croxford, Z Ward, R Ayres, C Lord, M Desai, E Emanuel, ... International Journal of Drug Policy 102, 103615, 2022 | 1 | 2022 |
| Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO A Artenie, N Luhmann, AG Lim, H Fraser, Z Ward, J Stone, L MacGregor, ... The Lancet Gastroenterology & Hepatology 7 (4), 353-366, 2022 | 18 | 2022 |
| The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study J Stone, A Artenie, M Hickman, NK Martin, L Degenhardt, H Fraser, ... The Lancet Public Health 7 (2), e136-e145, 2022 | 25 | 2022 |
| Web Annex C. 2. Impact of hepatitis C virus (HCV) point-of-care viral load testing versus laboratory-based testing on uptake of testing and treatment and turnaround times: a … A Trickey, E Fajardo, D Alemu, AA Artenie, P Easterbrook TREATMENT OF ADOLESCENTS AND CHILDREN WITH CHRONIC HCV INFECTION, AND HCV …, 2022 | | 2022 |
| Comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for HIV and hepatitis C virus … A Artenie, SN Facente, S Patel, J Stone, J Hecht, P Rhodes III, ... medRxiv, 2021.12. 09.21267273, 2021 | 1 | 2021 |
| Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs. J Grebely, AB Collins, AA Artenie, R Sutherland, JP Meyer, JA Barocas, ... | 12 | 2021 |
| Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada E Fortier, SB Høj, MP Sylvestre, AA Artenie, N Minoyan, D Jutras-Aswad, ... International Journal of Drug Policy 96, 103439, 2021 | 8 | 2021 |
